Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)

NCT07342621 is registered in ClinicalTrials.gov with Outcomes'10 as lead sponsor.

NCT NCT07342621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07342621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)
Lead sponsor
Outcomes'10
Phase
Observational
Overall status
Recruiting
Start date
February 7, 2025
Completion date
April 30, 2026
Enrollment
41 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

cow's milk protein allergy (cmpa), food hypersensitivity, gut microbiota, infant nutrition disorders